Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 228
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; Compass Talks Indication Expansion, Could VA Help?
From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT
Psychedelic Alpha Crossword: Summer 2026
Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at One Month
Psychedelic Policy Briefing: Week of July 27th, 2026
Complete Results from Red Light Oregon Market Research in Oregon Show...
Cybin Granted DEA Schedule I Manufacturing License
MINDCURE Provides Update on Studies and Clinical Trials
The Missing Mushroom: Psychedelic Science and the Future of Psilocybin
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy...
Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion...
PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development...
Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully...
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development...
Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker...
Load more
